arrow_back Back Filing freshness 10-Q Q1 FY2027 SEC EDGAR

ANGIODYNAMICS INC

ANGO
$11.82 ▼ -0.43 (-3.51%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
67 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
19
Health
Poor
Bearish
auto_awesome

Analytical Summary

ANGIODYNAMICS INC faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $496.7M
Dividend Yield —
Revenue Growth 6.9% ↘
Op. Margin -9.0% ↗
ROIC -4.3% ↗
FCF / Share $-0.37
Trailing P/E —
Price / Book 3.1x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

67-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$80.92M
↑ +6.9% —
Net Income Profit after all expenses
$-7.10M
↑ +34.9% —
Operating Margin Operating profit as % of sales
-9.0%
↑ +23.3% 9th
FCF / Share Free cash flow per share
$-0.37
↑ +7.5% —
Long-Term Debt Long-term obligations
$0.00
↓ -100.0% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓
13
Returns ↓
24
Cash Quality
20

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 18 years · 67 quarters